DrugPatentWatch Database Preview
Drugs in Development Information for Vadadustat
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Vadadustat?
Vadadustat is an investigational drug.
There have been 22 clinical trials for Vadadustat.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2016.
The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Kidney Diseases, and Anemia. The leading clinical trial sponsors are Akebia Therapeutics, Mitsubishi Tanabe Pharma Corporation, and [disabled in preview].
There are thirteen US patents protecting this investigational drug and one hundred and seven international patents.
Summary for Vadadustat
| US Patents | 13 |
| International Patents | 107 |
| US Patent Applications | 22 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2016-08-01) |
| Vendors | 24 |
Recent Clinical Trials for Vadadustat
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease | Akebia Therapeutics | Phase 1 |
| Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa | Akebia Therapeutics | Phase 2 |
| A Phase 1, Fixed Sequence, Open-label Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat | Akebia Therapeutics | Phase 1 |
Clinical Trial Summary for Vadadustat
Top disease conditions for Vadadustat
Top clinical trial sponsors for Vadadustat
US Patents for Vadadustat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Vadadustat | Start Trial | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | Akebia Therapeutics, Inc. (Cambridge, MA) | Start Trial |
| Vadadustat | Start Trial | Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides | Akebia Therapeutics, Inc. (Cambridge, MA) | Start Trial |
| Vadadustat | Start Trial | Prolyl hydroxylase inhibitors and methods of use | Warner Chilcott Company, LLC (Pajardo, PR) | Start Trial |
| Vadadustat | Start Trial | Prolyl hydroxylase inhibitors and methods of use | Akebia Therapeutics Inc. (Cincinnati, OH) | Start Trial |
| Vadadustat | Start Trial | Prolyl hydroxylase inhibitors and methods of use | Akebia Therapeutics Inc. (Cincinnati, OH) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Vadadustat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Vadadustat | Argentina | 099354 | 2033-11-15 | Start Trial |
| Vadadustat | Australia | 2014348523 | 2033-11-15 | Start Trial |
| Vadadustat | Australia | 2019202144 | 2033-11-15 | Start Trial |
| Vadadustat | Canada | 2930128 | 2033-11-15 | Start Trial |
| Vadadustat | Chile | 2016001150 | 2033-11-15 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
